Form 4: Mind Medicine (MindMed) CEO Sells Shares
Insider Transaction (Form 4)
Robert Barrow, Chief Executive Officer and a Director of Mind Medicine (MindMed) Inc., sold 19,023 shares of common stock on September 2, 2026 for $37.94 per share.
Summary
- Grant/award: acquired 40,000 Common Shares on September 2, 2026; holds 1,513,663 after (Direct).
- Open-market sale: disposed of 19,023 Common Shares at $37.94 ($721,733) on September 3, 2026; holds 1,494,640 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $721,733 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Robert Barrow — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Grant/award | Common Shares | 40,000 | — | — | 1,513,663 |
| 2026-09-03 | Open-market sale | Common Shares | 19,023 | $38 | $721.7K | 1,494,640 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Grant/award (40,000 shares) |
| 2026-09-03 | Open-market sale (19,023 shares) |
Keywords
insider transaction, Form 4, DFTX, Definium Therapeutics, Inc., bearish, Robert Barrow
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.